文献速递支持与姑息治疗

电针或耳针与常规护理对癌症幸存者慢性肌肉骨骼疼痛的效果:PEACE随机临床试验

Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial.
PubMed 文献 · JAMA Oncol · 2021-01-01

PEACE随机临床试验纳入360例无疾病证据但伴慢性肌肉骨骼疼痛的癌症幸存者,按2:2:1随机接受电针、耳针或常规护理。第12周时,电针和耳针较常规护理分别降低疼痛评分1.9分和1.6分,但耳针未证明非劣于电针,且耳针因不良事件停药比例更高。

要点

  • 电针和耳针均较常规护理显著降低癌症幸存者慢性肌肉骨骼疼痛。
  • 耳针未证明非劣于电针,且不良事件导致停药的比例显著更高。
  • 电针因不良事件停药率仅0.7%,安全性较好。

核心结论

  • 在癌症幸存者慢性肌肉骨骼疼痛中,电针和耳针均比常规护理产生更大的疼痛缓解。
  • 耳针未证明非劣于电针,且接受耳针的患者不良事件更多。

研究设计与样本

  • PEACE试验为随机临床试验,2017年3月至2019年10月在纽约和新泽西的城市学术癌症中心及5个郊区站点开展。
  • 360例有既往癌症诊断但无当前疾病证据、肌肉骨骼疼痛至少3个月、简明疼痛量表(BPI)评分0-10的成人纳入研究。
  • 患者按2:2:1随机分为电针组(n=145)、耳针组(n=143)或常规护理组(n=72)。
  • 干预组接受10次每周一次的电针或耳针治疗;常规护理组在第12至24周接受10次针灸治疗。
  • 主要结局为BPI平均疼痛严重程度评分从基线至第12周的变化。

主要发现

  • 360例癌症幸存者平均(SD)年龄62.1(12.7)岁,平均(SD)基线BPI评分5.2(1.7)分,女性251例(69.7%),非白人88例(24.4%)。
  • 340例(94.4%)完成了主要终点。
  • 与常规护理相比,电针从基线至第12周降低疼痛严重程度1.9分(97.5% CI,1.4-2.4分;P < .001)。
  • 与常规护理相比,耳针从基线至第12周降低疼痛严重程度1.6分(97.5% CI,1.0-2.1分;P < .001)。
  • 耳针相对于电针的非劣效性未得到证明。

关键数值与推荐

  • 电针组145例中1例(0.7%)因不良事件停止治疗,耳针组143例中15例(10.5%)因不良事件停止治疗(P < .001)。
  • 不良事件均为轻度。

临床怎么用

  • 对于癌症幸存者慢性肌肉骨骼疼痛,电针和耳针均可考虑作为常规护理的补充以减轻疼痛。
  • 选择耳针时需注意其不良事件导致停药的风险高于电针。

局限性

  • 常规护理组在第12至24周接受针灸治疗,可能影响长期比较。
  • 耳针相对于电针的非劣效性未得到证明,不能认为两者等效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The opioid crisis creates challenges for cancer pain management. Acupuncture confers clinical benefits for chronic nonmalignant pain, but its effectiveness in cancer survivors remains uncertain. OBJECTIVE: To determine the effectiveness of electroacupuncture or auricular acupuncture for chronic musculoskeletal pain in cancer survivors. DESIGN, SETTING, AND PARTICIPANTS: The Personalized Electroacupuncture vs Auricular Acupuncture Comparative Effectiveness (PEACE) trial is a randomized clinical trial that was conducted from March 2017 to October 2019 (follow-up completed April 2020) across an urban academic cancer center and 5 suburban sites in New York and New Jersey. Study statisticians were blinded to treatment assignments. The 360 adults included in the study had a prior cancer diagnosis but no current evidence of disease, reported musculoskeletal pain for at least 3 months, and self-reported pain intensity on the Brief Pain Inventory (BPI) ranging from 0 (no pain) to 10 (worst pain imaginable). INTERVENTIONS: Patients were randomized 2:2:1 to electroacupuncture (n = 145), auricular acupuncture (n = 143), or usual care (n = 72). Intervention groups received 10 weekly sessions of electroacupuncture or auricular acupuncture. Ten acupuncture sessions were offered to the usual care group from weeks 12 through 24. MAIN OUTCOMES AND MEASURES: The primary outcome was change in average pain severity score on the BPI from baseline to week 12. Using a gatekeeping multiple-comparison procedure, electroacupuncture and auricular acupuncture were compared with usual care using a linear mixed model. Noninferiority of auricular acupuncture to electroacupuncture was tested if both interventions were superior to usual care. RESULTS: Among 360 cancer survivors (mean [SD] age, 62.1 [12.7] years; mean [SD] baseline BPI score, 5.2 [1.7] points; 251 [69.7%] women; and 88 [24.4%] non-White), 340 (94.4%) completed the primary end point. Compared with usual care, electroacupuncture reduced pain severity by 1.9 points (97.5% CI, 1.4-2.4 points; P < .001) and auricular acupuncture reduced by 1.6 points (97.5% CI, 1.0-2.1 points; P < .001) from baseline to week 12. Noninferiority of auricular acupuncture to electroacupuncture was not demonstrated. Adverse events were mild; 15 of 143 (10.5%) patients receiving auricular acupuncture and 1 of 145 (0.7%) patients receiving electroacupuncture discontinued treatments due to adverse events (P < .001). CONCLUSIONS AND RELEVANCE: In this randomized clinical trial among cancer survivors with chronic musculoskeletal pain, electroacupuncture and auricular acupuncture produced greater pain reduction than usual care. However, auricular acupuncture did not demonstrate noninferiority to electroacupuncture, and patients receiving it had more adverse events. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02979574.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Mao JJ, Liou KT, Baser RE, et al. Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial. JAMA Oncol. 2021. PMID: 33734288. doi:10.1001/jamaoncol.2021.0310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。